A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP
Clinical trial NCT04428255 · COMPLETED
Trial details
- NCT number
- NCT04428255
- Sponsor
- Harbour BioMed (Guangzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-24
- Primary completion
- 2021-08-10
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.